Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tanno, Y.
Right arrow Articles by Hosoya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanno, Y.
Right arrow Articles by Hosoya, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: III97-III98
© 2003 European Renal Association-European Dialysis and Transplant Association

Original Article

IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker

Yudo Tanno1,, Keitaro Yokoyama1, Masaaki Nakayama1, Akihiko Katoh1, Hiroyasu Yamamoto1, Yoshiko Iwasaki2, Tom Cantor3, Masafumi Fukagawa4, Takashi Shigematsu1 and Tatsuo Hosoya1

1 The Division of Kidney and Hypertension, Jikei University School of Medicine, Tokyo, 2 Tokyo Teisin Hospital, Tokyo, 4 Division of Metabolic Disease, Kobe University School of Medicine, Hyogo, Japan and 3 Scantibodies Laboratory Santee, USA

The common intact parathyroid hormone (i-PTH) assay detects not only PTH (1–84) but also the PTH (7–84) fragment. Recently, it was reported that the PTH (7–84) fragment is an antagonist to the biological action of PTH (1–84). It was also reported that the accumulation of the PTH (7–84) fragment plays a role in skeletal resistance in haemodialysis (HD) patients. However, the role of accumulation of the PTH (7–84) fragment in continuous ambulatory peritoneal dialysis (CAPD) patients, with a different clearance rate from that of HD patients, is still unclear. Therefore, we have measured only the active form of PTH (1–84) using a new method of whole PTH (w-PTH) assay in 20 CAPD patients (15 male and five female; mean age 51.0±13.0 years). The mean w-PTH value was 88.5 ±14.2 pg/ml in CAPD patients, which was 42.1% of i-PTH (152.6±23.6 pg/ml). The approximate value of w-PTH was calculated using the following formula (w-PTH=0.58xiPTH–0.4, R2=0.94). PTH (7–84) fragment was calculated by the formula i-PTH–w-PTH. The PTH (7–84) fragment/w-PTH ratio as an index of skeletal resistance, and serum alkaline phosphatase activity as an osteoblastic marker were negatively correlated (P=0.02). From these results, we concluded that the i-PTH level as calculated using the common assay method might lead to an overestimation of parathyroid function and bone turnover in CAPD patients similarly to HD patients. The w-PTH assay may be useful for more precise evaluation of PTH activity in end-stage renal disease patients.

Keywords: CAPD; end-stage renal disease; low turnover bone disease; PTH (7–84)/PTH (1–84) ratio; skeletal resistance; whole PTH assay

Correspondence and offprint requests to: Yudo Tanno MD, The Division of Kidney and Hypertension, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi Minato-ku, Tokyo 105-8471, Japan. Email: tanno{at}jikei.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.